NFKB1 and fatty liver disease: In previous reports, hepatic overexpression of SAA1 aggravated fatty liver inflammation by promoting intrahepatic platelet aggregation [73], while, recently, SAA1 was shown to exacerbate hepatic steatosis via the TLR4-mediated NF-κB signaling pathway [74].